Brentuximab-Vedotin+AVDDespite being very effective and having a high tollerance, this combination is commonly used in adult settings, there are same Phase II studies demonstrating its effectiveness in paediatric settings, but for now it's not the standard of care. |
Map: LLA in 8 years old Child (1046)
|
||
|
Review your pathway |
